Cerner hires new execs, extends Intermountain Healthcare partnership

Cerner Corporation, a health information and EHR technology company, has extended its partnership with not-for-profit healthcare company Intermountain Healthcare in a multiyear agreement.

Cerner also announced the appointment of two new executives.

The agreement between Cerner and Intermountain means that Cerner will continue to provide the healthcare organization with Cerner technology across Intermountain’s 24 hospitals, 2,400 physicians and 210 clinics.

“The partnership between Cerner and Intermountain has never been stronger,” Marc Probst, vice president and CIO of Intermountain Healthcare, said in statement. “We continue to diligently work toward the goals we set out to accomplish together and have a renewed sense of pride about this relationship and where we are headed.”

“Our renewed commitment with Intermountain is a result of what we can achieve when we put our minds together and focus on what’s really important, improving patients’ health and clinicians’ ability to provide potentially lifesaving care,” Brent Shafer, chairman and CEO of Cerner, said in the same statement. “We are focused on supporting our clients with the resources they need to succeed, and as one of the most robust users of our technology, Intermountain is an outstanding example of the advancements a relationship like this can bring.”

New hires

At the same time, Cerner announced the appointment of Don Trigg as president of the company and John Peterzalek to chief client and services officer.

Trigg, who has been with Cerner since 2002, will be responsible for clinical EHR, revenue cycle management and strategic growth businesses, such as real-time health systems, health networks, data-as-a-service, long-term and post-acute care, consumer and employer.

As chief client and services officer, Peterzalek will be responsible for Cerner’s services, consulting, support and hosting. Peterzalek joined Cerner in 2003 and will continue to oversee worldwide client relationship management and sales.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.